Aptose Biosciences Inc. (TSX:APS)
Canada · Delayed Price · Currency is CAD 2.230
+0.010 (0.45%)
At close: Mar 20, 2026
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of CAD 5.69 million as of March 20, 2026. Its market cap has decreased by -65.95% in one year.
Market Cap
5.69M
Enterprise Value
31.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.23
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 47.29M to 5.69M, a decrease of -87.96%. That is a compound annual growth rate of -6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 5.69M | 5.19% |
| Dec 31, 2025 | 5.41M | -72.33% |
| Dec 31, 2024 | 19.56M | -26.49% |
| Dec 29, 2023 | 26.61M | -63.04% |
| Dec 30, 2022 | 71.99M | -53.23% |
| Dec 31, 2021 | 153.93M | -69.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glow Lifetech | 9.08M |
| Innovotech | 8.32M |
| PharmaTher Holdings | 6.37M |
| Restart Life Sciences | 5.93M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| XORTX Therapeutics | 4.46M |